July 19 (Reuters) - Activist shareholder Elliott Investment Management has built a significant stake in Catalent CTLT.N and is pushing for a shake-up on the contract drugmaker's board, the Wall Street Journal reported on Wednesday. (Reporting by Lavanya Ahire in Bengaluru; Editing by Shailesh Kuber)((LavanyaSushil.Ahire@thomsonreuters.com;))The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source: Wall Street Journal July 19, 2023 23:21 UTC